We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Tests Diagnose Mental Health Conditions

By Biotechdaily staff writers
Posted on 13 Mar 2007
Blood tests are being developed for panic disorder and other mental health conditions. More...


The findings of University of Iowa (UI; Iowa City, IA, USA) investigators were based on the analysis of genetic information in immature white blood cells and appear online in the March 6, 2007, American Journal of Medical Genetics.

The ability to test for panic disorder is a quantum leap in psychiatry, said the study's lead author, Robert Philibert, M.D., Ph.D., professor of psychiatry in the UI Roy J. and Lucille A. Carver College of Medicine. Panic disorder will no longer be a purely descriptive diagnosis, but, as with cystic fibrosis, Down syndrome, and other conditions, a diagnosis based on genetic information, he said. In addition, the finding could help us better understand the pathways that initiate, promote, and maintain panic disorder.

The team compared gene expression in lymphoblasts (immature white blood cells) culled from 16 participants with panic disorder and 17 participants without the disorder. The study found many genes were more expressed in people with panic disorder than in people without the condition. Similarly, the study found many genes were less expressed in people with panic disorder. There were also sex-related differences.

Overall, people with panic disorder had noticeably different patterns of gene expression than people without the disorder. Although panic disorder is a disease of brain cells, the study used lymphoblasts as stand-ins for the genetic testing because brain cells are not accessible or easily tested.

Panic attacks can involve up to 10 symptoms, including palpitations, shortness of breath, sweating, and a feeling of loss of control or dying--symptoms that are very similar to heart attack symptoms. People with panic disorder often end up in the emergency room for heart tests when in fact they have panic disorder. This is just one of the reasons that it would be helpful to have a blood test for panic disorder, Dr. Philibert said. If we can, it could help us identify systems that interact with the environment and possibly lead the way to new, even non-drug, therapies to prevent illness,

A blood test for commercial use is now being developed by the UI, which raises larger questions about how information revealed by such tests will be used. The issue of patient medical records and how they can potentially be used by employers, insurers, government agencies, and other institutions is a concern, according to Prof. Philibert.



Related Links:
University of Iowa

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Clinical Informatics Platform
CLARION™
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.